R G Wickremasinghe

666 total citations
25 papers, 537 citations indexed

About

R G Wickremasinghe is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, R G Wickremasinghe has authored 25 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in R G Wickremasinghe's work include Chronic Lymphocytic Leukemia Research (8 papers), Drug Transport and Resistance Mechanisms (3 papers) and Biochemical and Molecular Research (3 papers). R G Wickremasinghe is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Drug Transport and Resistance Mechanisms (3 papers) and Biochemical and Molecular Research (3 papers). R G Wickremasinghe collaborates with scholars based in United Kingdom and United States. R G Wickremasinghe's co-authors include A. V. Hoffbrand, Mohammad Taheri‬, Andrew J. Steele, A. G. Prentice, K. Ganeshaguru, Atul Mehta, A. V. Hoffbrand, A. Victor Hoffbrand, G. E. Francis and Dylan T. Jones and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

R G Wickremasinghe

25 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R G Wickremasinghe United Kingdom 16 299 109 92 81 75 25 537
Luciana Pizzatti Brazil 19 414 1.4× 119 1.1× 150 1.6× 68 0.8× 23 0.3× 34 708
Huihong You United States 10 274 0.9× 35 0.3× 70 0.8× 47 0.6× 19 0.3× 13 522
J S Wax United States 13 258 0.9× 55 0.5× 141 1.5× 217 2.7× 43 0.6× 16 592
Paolo Pagani Italy 7 652 2.2× 50 0.5× 177 1.9× 128 1.6× 30 0.4× 17 851
Ali Memarian Iran 16 198 0.7× 103 0.9× 140 1.5× 43 0.5× 90 1.2× 37 648
Timothy S. Collins United States 9 252 0.8× 26 0.2× 146 1.6× 37 0.5× 32 0.4× 10 461
Karen M. Doody Canada 12 423 1.4× 154 1.4× 100 1.1× 38 0.5× 52 0.7× 15 679
K Sampi Japan 11 199 0.7× 105 1.0× 137 1.5× 162 2.0× 10 0.1× 55 476
André Limnander United States 12 242 0.8× 42 0.4× 149 1.6× 56 0.7× 18 0.2× 17 512
Qi Zhu China 12 245 0.8× 18 0.2× 55 0.6× 80 1.0× 90 1.2× 35 450

Countries citing papers authored by R G Wickremasinghe

Since Specialization
Citations

This map shows the geographic impact of R G Wickremasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R G Wickremasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R G Wickremasinghe more than expected).

Fields of papers citing papers by R G Wickremasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R G Wickremasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R G Wickremasinghe. The network helps show where R G Wickremasinghe may publish in the future.

Co-authorship network of co-authors of R G Wickremasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of R G Wickremasinghe. A scholar is included among the top collaborators of R G Wickremasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R G Wickremasinghe. R G Wickremasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wickremasinghe, R G, A. G. Prentice, & Andrew J. Steele. (2011). p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. Leukemia. 25(9). 1400–1407. 49 indexed citations
2.
Steele, Andrew J., A. G. Prentice, Anastasios Chanalaris, et al.. (2009). Induction of Noxa Via Generation of Reactive Oxygen Species Plays a Key Role in Induction of CLL Cell Apoptosis by Two Novel p53-Independent Cytotoxic Agents.. Blood. 114(22). 2752–2752. 3 indexed citations
3.
Steele, Andrew J., Dylan T. Jones, K. Ganeshaguru, et al.. (2006). The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia. 20(6). 1073–1079. 63 indexed citations
4.
Stubbs, Mark, et al.. (2005). CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. Oncology Reports. 14(4). 1055–8. 5 indexed citations
5.
Folarin, Najeem, Robert J. Baker, Veronique Duke, et al.. (2004). Zap-70 and IgVH Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.. Blood. 104(11). 1907–1907. 1 indexed citations
6.
Virchis, Andres, K. Ganeshaguru, Stephen L. Hart, et al.. (2002). A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. The Hematology Journal. 3(3). 131–136. 27 indexed citations
7.
Lowdell, Mark W., et al.. (2001). Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein. Cancer Letters. 164(1). 77–84. 20 indexed citations
8.
Ng, Tony, Irene Collins, Steven B. Kanner, et al.. (1999). Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus. Lupus. 8(1). 39–51. 5 indexed citations
9.
Ng, Tony, Steven B. Kanner, Martin J. Humphries, et al.. (1997). The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals. The Journal of Immunology. 158(6). 2984–2999. 14 indexed citations
10.
Ganeshaguru, K., et al.. (1995). Deletion of chromosome 13 (band ql4) but not trisomy 12 is a clonal event in B‐chronic lymphocytic leukaemia (CLL). British Journal of Haematology. 90(2). 476–478. 19 indexed citations
11.
Khan, Masood, et al.. (1993). MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells. Leukemia Research. 17(9). 759–762. 27 indexed citations
12.
Wickremasinghe, R G, Masood Khan, & A. V. Hoffbrand. (1993). Do leukotrienes play a role in the regulation of proliferation of normal and leukemic hemopoietic cells?. Prostaglandins Leukotrienes and Essential Fatty Acids. 48(2). 123–126. 15 indexed citations
13.
Porfiri, Emilio, et al.. (1992). Impaired degradation of Ca(2+)-regulating second messengers in myeloid leukemia cells. Implications for the regulation of leukemia cell proliferation.. PubMed. 6(8). 801–5. 5 indexed citations
14.
Mire‐Sluis, Anthony R., R G Wickremasinghe, A. Victor Hoffbrand, Anthony Timms, & G. E. Francis. (1987). Human T lymphocytes stimulated by phytohaemagglutinin undergo a single round of cell division without a requirement for interleukin-2 or accessory cells.. PubMed. 60(1). 7–12. 23 indexed citations
15.
EVANS, JEFF, R G Wickremasinghe, & A. V. Hoffbrand. (1987). Detection of tyrosine protein kinase substrates in fresh leukemia cells and normal blood cells using an immunoblotting technique.. PubMed. 1(11). 782–5. 4 indexed citations
16.
Piga, A., et al.. (1985). Phytohemagglutinin-induced changes in tyrosine protein kinase and its endogenous substrates in human lymphocytes. Experimental Cell Research. 159(1). 103–112. 14 indexed citations
17.
Wickremasinghe, R G, et al.. (1982). The effect of folate analogues and vitamin B12 on provision of thymine nucleotides for DNA synthesis in megaloblastic anemia. Blood. 59(3). 634–640. 17 indexed citations
18.
Taheri‬, Mohammad, R G Wickremasinghe, & A. V. Hoffbrand. (1981). Metabolism of thymine nucleotides synthesized via the ‘de novo’ mechanism in normal, megaloblastic and methotrexate-treated human cells and in a lymphoblastoid cell line. Biochemical Journal. 196(1). 225–235. 29 indexed citations
19.
Wickremasinghe, R G & A. V. Hoffbrand. (1980). Reduced rate of DNA replication fork movement in megaloblastic anemia.. Journal of Clinical Investigation. 65(1). 26–36. 55 indexed citations
20.
Wickremasinghe, R G, et al.. (1977). Differential N‐ethylmaleimide inhibition of two enzymes of the DNA α‐polymerase‐fraction from calf thymus. FEBS Letters. 78(1). 139–142. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciana Pizzatti Breakdown of academic impact, for papers by Huihong You Breakdown of academic impact, for papers by J S Wax Breakdown of academic impact, for papers by Paolo Pagani Breakdown of academic impact, for papers by Ali Memarian Breakdown of academic impact, for papers by Timothy S. Collins Breakdown of academic impact, for papers by Karen M. Doody Breakdown of academic impact, for papers by K Sampi Breakdown of academic impact, for papers by André Limnander Breakdown of academic impact, for papers by Qi Zhu
Rankless by CCL
2026